About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Identifying Prostate Brachytherapy Seeds Using MRI

NCT01878058·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Health Network, Toronto

With

Princess Margaret Hospital, Canada

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

1. At least 18 years old
2. Histologic diagnosis of adenocarcinoma of the prostate
3. No contraindications for Pelvic body MRI
4. Patients undergoing LDR brachytherapy at PMH and scheduled for post implant analysis with CT-MR (standard at PMH)
5. Ability to provide written informed consent to participate in the study

You may not be if

1. Contraindication for Pelvic body MRI
2. Patient not willing/consenting for this study

The record

StatusCompleted

PhaseNo phase

Taking part10

StartedOct 2012

UpdatedNov 1, 2016

Conditions

Prostate Cancer Patients Who Have Brachytherapy Seed Implant

Where1

University Health Network, The Princess Margaret
Toronto, Ontario, Canada

Clareo Health | Identifying Prostate Brachytherapy Seeds Using MRI